SynthesisMedicine2026

Efficacy and safety of first-line immune checkpoint inhibitors combinations for extensive-stage small-cell lung cancer: A systematic review and network meta-analysis.

Xi Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.